IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Ending Cash Position: ₹0 Mil (As of Mar. 2026)


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
57 GF Score
Price ₹171.06
GF Value ₹94.18
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Ending Cash Position?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +1.73% 57 Ending Cash Position is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:IOLCP with a GF Score™ of 57/100 and a GF Value™ of ₹94.18 (Significantly Overvalued). The stock has 7 warning signs investors should review.

IOL Chemicals And Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2026 was ₹0 Mil.

IOL Chemicals And Pharmaceuticals's annual Ending Cash Position increased from Mar. 2024 (₹77 Mil) to Mar. 2025 (₹782 Mil) but then declined from Mar. 2025 (₹782 Mil) to Mar. 2026 (₹654 Mil).

IOL Chemicals And Pharmaceuticals Ending Cash Position Related Terms

IOL Chemicals And Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Ending Cash Position Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.30 13.90 76.90 781.70 653.50

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:IOLCP
57GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

IOL Chemicals And Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=781.7+-128.2
=654

IOL Chemicals And Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₹0 Mil mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Ending Cash Position of ₹0 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on IOL Chemicals And Pharmaceuticals and its competitors.
Is IOL Chemicals And Pharmaceuticals' Ending Cash Position too high?
IOL Chemicals And Pharmaceuticals' current Ending Cash Position is ₹0 Mil. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Ending Cash Position compare to ZTS and UTHR?
IOL Chemicals And Pharmaceuticals' Ending Cash Position of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. IOL Chemicals And Pharmaceuticals's current Ending Cash Position is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹94.18, compared to a current price of ₹171.06 — trading 81.6% above its estimated fair value. The current Ending Cash Position is ₹0 Mil. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Ending Cash Position is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹171.06 is trading 81.6% above its estimated GF Value™ of ₹94.18. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Ending Cash Position: ₹0 Mil
  • GF Value™: ₹94.18 vs. price of ₹171.06 (81.6% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
57GF Score

Get the complete analysis for NSE:IOLCP

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹171.06
Price
₹94.18
GF Value